Key result
Medical therapy stabilizes advanced rheumatic heart disease during pregnancy when definitive intervention is unavailable.
Why the study?
Rheumatic heart disease remains a major cause of maternal cardiovascular morbidity and mortality in low-resource settings, where pregnancy-related physiological changes can unmask or decompensate valvular lesions.
Case Report (n=3)
No
This case series highlights the severe morbidity of rheumatic heart disease in pregnancy in resource-limited settings and the critical gaps in access to definitive interventions like percutaneous balloon mitral valvotomy.
Answers are grounded in this paper and cite their sources.
Medical stabilization may temporize severe RHD in pregnancy; leaves open scalable access to valvotomy in low-resource settings.
Rheumatic heart disease (RHD) remains a major cause of maternal cardiovascular morbidity and mortality in low-resource settings, particularly among women of reproductive age. Physiological changes during pregnancy can unmask previously undiagnosed disease or precipitate decompensation in those with established valvular lesions. We present a case series of three women with RHD during pregnancy and the early postpartum period, highlighting the burden, clinical presentation, and management challenge in a resource-limited setting. All patients presented with advanced disease, including severe mitral stenosis, atrial fibrillation, and heart failure, with one case complicated by multivalvular involvement and reduced left ventricular function. Management focused on hemodynamic stabilization using diuretics, rate control, anticoagulation, and multidisciplinary care. Definitive interventions such as percutaneous balloon mitral valvotomy or valve replacement were indicated but deferred due to limited availability and financial constraints. All three mothers were clinically stabilized and remained alive at short-term follow-up, although one preterm neonate died from respiratory distress syndrome and Case 3 required readmission because of medication nonadherence. This series underscores the persistent burden of RHD in pregnancy in sub-Saharan Africa and highlights critical gaps in access to definitive cardiac interventions and anticoagulation monitoring. Strengthening health systems, improving access to specialized cardiac care, and implementing preventive strategies are essential to reduce morbidity and mortality associated with RHD in pregnancy in resource-limited settings.
No takes yet. Share an insight, caveat, or question.
Mwemezi et al. (2026) conducted a case report in Rheumatic heart disease in pregnancy (n=3). Rheumatic heart disease was evaluated. Three pregnant women with advanced rheumatic heart disease were clinically stabilized with medical therapy, though definitive interventions were deferred due to resource constraints.
Synapse has enriched 10 related papers. Consider them for comparative context: